Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KH607 in Postpartum Depressive Disorder
NCT07096791Phase 2Completed
- Sponsor
- Chengdu Kanghong Pharmaceutical Group Co., Ltd.
- Start
- Sep 2025
- Primary completion
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of KH607 in postpartum depression (PPD), sponsored by Chengdu Kanghong Pharmaceutical Group Co., Ltd.. Started Sep 2025; status: completed.
02
Drugs
KH607
03
Conditions
postpartum depression (PPD)
Beyond the preview
Go deeper on NCT07096791.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07096791.